Long-Term Safety Extension Study of ACTIMMUNE® (Interferon γ-1b) in Children and Young Adults With Friedreich's Ataxia
Clinical trial NCT02797080 · COMPLETED
Trial details
- NCT number
- NCT02797080
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-28
- Primary completion
- 2017-03-31
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.